• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E

机构信息

European School of Oncology, Milan, Italy.

出版信息

Ann Oncol. 2012 Oct;23 Suppl 7:vii11-9. doi: 10.1093/annonc/mds232.

DOI:10.1093/annonc/mds232
PMID:22997442
Abstract
摘要

相似文献

1
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.局部复发或转移性乳腺癌：ESMO临床实践指南之诊断、治疗与随访
Ann Oncol. 2012 Oct;23 Suppl 7:vii11-9. doi: 10.1093/annonc/mds232.
2
[Diagnosis and therapy of advanced breast carcinoma: summary of the NICE guidelines].[晚期乳腺癌的诊断与治疗：英国国家卫生与临床优化研究所指南总结]
Praxis (Bern 1994). 2009 Aug 26;98(17):961-4. doi: 10.1024/1661-8157.98.17.961.
3
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.局部复发或转移性乳腺癌：ESMO临床实践指南之诊断、治疗及随访
Ann Oncol. 2011 Sep;22 Suppl 6:vi25-30. doi: 10.1093/annonc/mdr372.
4
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.局部复发或转移性乳腺癌：ESMO临床实践指南之诊断、治疗与随访
Ann Oncol. 2010 May;21 Suppl 5:v15-9. doi: 10.1093/annonc/mdq160.
5
Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.局部复发或转移性乳腺癌：欧洲肿瘤内科学会关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii11-3. doi: 10.1093/annonc/mdn072.
6
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC).欧洲肿瘤内科学会（ESMO）关于局部复发或转移性乳腺癌（MBC）诊断、治疗及随访的最低临床建议。
Ann Oncol. 2005;16 Suppl 1:i10-2. doi: 10.1093/annonc/mdi816.
7
Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.局部复发或转移性乳腺癌：欧洲肿瘤内科学会关于诊断、治疗及随访的临床建议
Ann Oncol. 2009 May;20 Suppl 4:15-8. doi: 10.1093/annonc/mdp115.
8
Synchronous metastatic breast cancer in a husband and wife.一对夫妻均患同步转移性乳腺癌。
Ir J Med Sci. 1996 Jan-Mar;165(1):50. doi: 10.1007/BF02942804.
9
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.软组织和内脏肉瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2012 Oct;23 Suppl 7:vii92-9. doi: 10.1093/annonc/mds253.
10
Primary osteosarcoma of the breast.乳腺原发性骨肉瘤
Breast Cancer. 2004;11(4):396-400. doi: 10.1007/BF02968048.

引用本文的文献

1
Comparing the diagnostic efficacy of [F]FDG PET/CT and [F]FDG PET/MRI in breast cancer recurrence: a systematic review and meta-analysis.比较[F]FDG PET/CT与[F]FDG PET/MRI对乳腺癌复发的诊断效能：一项系统评价与Meta分析。
Front Med (Lausanne). 2025 Aug 1;12:1602415. doi: 10.3389/fmed.2025.1602415. eCollection 2025.
2
Comparative long-term outcomes of first-line CDK4/6 inhibitors plus endocrine therapy versus endocrine therapy in patients with HR+/HER2-metastatic or advanced breast cancer: a meta-analysis.一线CDK4/6抑制剂联合内分泌治疗与内分泌治疗用于HR+/HER2-转移性或晚期乳腺癌患者的比较长期结局：一项荟萃分析。
Front Pharmacol. 2025 Jul 25;16:1600892. doi: 10.3389/fphar.2025.1600892. eCollection 2025.
3
Survival prognosis evaluation in advanced breast cancer patients: a study on the application of the advanced lung cancer inflammation index.
晚期乳腺癌患者的生存预后评估：一项关于晚期肺癌炎症指数应用的研究
Front Oncol. 2025 Jun 4;15:1598069. doi: 10.3389/fonc.2025.1598069. eCollection 2025.
4
Prognostic model for predicting recurrence in breast cancer patients in Saudi Arabia.沙特阿拉伯乳腺癌患者复发预测的预后模型。
Sci Rep. 2025 May 26;15(1):18388. doi: 10.1038/s41598-025-94530-z.
5
Structural insights and predictive modelling of a novel anti-HER2 scFv and Leptulipin: a newly designed immunotoxin protein for HER2 positive cancers.一种新型抗HER2单链抗体片段和瘦素脂肽的结构见解与预测模型：一种新设计的用于HER2阳性癌症的免疫毒素蛋白。
Toxicol Res (Camb). 2025 May 24;14(3):tfaf060. doi: 10.1093/toxres/tfaf060. eCollection 2025 Jun.
6
Metastasizing to the colon from triple-negative breast cancer: A case report and review of literature.三阴性乳腺癌转移至结肠：一例病例报告及文献综述
World J Gastrointest Oncol. 2025 Mar 15;17(3):103328. doi: 10.4251/wjgo.v17.i3.103328.
7
Medication patterns and potentially inappropriate medication in patients with metastatic breast cancer: results of the BRE-BY-MED study.转移性乳腺癌患者的用药模式及潜在不适当用药：BRE-BY-MED研究结果
BMC Cancer. 2025 Jan 22;25(1):125. doi: 10.1186/s12885-025-13548-8.
8
An early economic evaluation of active surveillance for low-risk ductal carcinoma .低风险导管癌主动监测的早期经济学评估
Future Oncol. 2024 Dec;20(40):3451-3462. doi: 10.1080/14796694.2024.2421152. Epub 2024 Dec 16.
9
Design and computational analysis of a novel Azurin-BR2 chimeric protein against breast cancer.一种新型抗乳腺癌天青蛋白-BR2嵌合蛋白的设计与计算分析
Toxicol Res (Camb). 2024 Nov 5;13(6):tfae179. doi: 10.1093/toxres/tfae179. eCollection 2024 Dec.
10
Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell .免疫相关基因多态性对曲妥珠单抗靶向乳腺癌细胞的影响。
Pharmacogenomics. 2024;25(10-11):461-468. doi: 10.1080/14622416.2024.2404819. Epub 2024 Oct 11.